Literature DB >> 8061330

Oncogenes and muscle differentiation: multiple mechanisms of interference.

S Alemà1, F Tatò.   

Abstract

In vitro transformation of replicating myogenic cells by a variety of oncogenes is always accompanied by inhibition of the transition to the terminally differentiated state. Three main levels of interference by oncogenes may ultimately prevent transcription of skeletal muscle-specific genes. First, the transcription of muscle-regulatory factors (MRF) of the MyoD family can be extinguished in transformed myoblasts. Second, several oncoproteins are capable of silencing the transcriptional capacity of MRF. Third, the DNA binding activity of MRF can be negatively modulated by phosphorylation or competition by dominant negative partners. Oncogenes can function at multiple potential levels of regulation, depending on the myogenic cell context.

Mesh:

Substances:

Year:  1994        PMID: 8061330

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  10 in total

1.  A role for the putative tumor suppressor Bin1 in muscle cell differentiation.

Authors:  R J Wechsler-Reya; K J Elliott; G C Prendergast
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

2.  Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen.

Authors:  D Tedesco; L Baron; L Fischer-Fantuzzi; C Vesco
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps.

Authors:  Z Wu; P J Woodring; K S Bhakta; K Tamura; F Wen; J R Feramisco; M Karin; J Y Wang; P L Puri
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Signaling through mitogen-activated protein kinase and Rac/Rho does not duplicate the effects of activated Ras on skeletal myogenesis.

Authors:  M B Ramocki; S E Johnson; M A White; C L Ashendel; S F Konieczny; E J Taparowsky
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

5.  Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells.

Authors:  P L Puri; Z Wu; P Zhang; L D Wood; K S Bhakta; J Han; J R Feramisco; M Karin; J Y Wang
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

6.  The anti-cancer agent distamycin A displaces essential transcription factors and selectively inhibits myogenic differentiation.

Authors:  A Taylor; K A Webster; T A Gustafson; L Kedes
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

7.  Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors.

Authors:  Y Kong; S E Johnson; E J Taparowsky; S F Konieczny
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  Distinct effects of Rac1 on differentiation of primary avian myoblasts.

Authors:  R Gallo; M Serafini; L Castellani; G Falcone; S Alemà
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

9.  The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants.

Authors:  D Tedesco; M Caruso; L Fischer-Fantuzzi; C Vesco
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation.

Authors:  R A Screaton; L Z Penn; C P Stanners
Journal:  J Cell Biol       Date:  1997-05-19       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.